The role of neurotrophic factors in disorders of peripheral nerves and motor neurons

Physical Medicine and Rehabilitation Clinics of North America

Volumn 12, Issue 2, 2001, Pages 293-306

  Yuen, E C ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; NEUROTROPHIN; SOMATOMEDIN C;

CELL DIFFERENTIATION; CELL SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; DRUG EFFICACY; HUMAN; MOTOR NEURON DISEASE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW;

EID: 0035039720     PISSN: 10479651     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1047-9651(18)30070-6     Document Type: Review

References (56)

1. Overexpression of nerve growth factor in epidermis of transgenic mice causes hypertrophy of the peripheral nervous system
2. The role of endogenous nerve growth factor in human diabetic neuropathy
3. Nerve growth factor administration protects against experimental diabetic sensory neuropathy
4. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy: NGF Study Group
5. Survival effect of ciliary neurotrophic factor (CNTF) on chick embryonic motoneurons in culture: Comparison with other neurotrophic factors and cytokines
6. A controlled trial of recombinant methionyl human BDNF in ALS
7. A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis: European ALS/IGF-I Study Group
8. A Phase I/II study of recombinant human brain-derived neurotrophic factor in patients with amyotrophic lateral sclerosis
9. Diabetic neuropathy, nerve growth factor and other neurotrophic factors
10. Activity-sensitive signaling by muscle-derived insulin-like growth factors in the developing and regenerating neuromuscular system
11. Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors
12. Neurotrophins in cell survival/death decisions
13. rhIGF-I enhances functional recovery from sciatic crushed. Time-course and dose-response study
14. Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons
15. Expression of neuropeptides in experimental diabetes: Effects of treatment with nerve growth factor or brain-derived neurotrophic factor
16. Increased nerve growth factor mRNA in lateral calf skin biopsies from diabetic patients
17. Diabetic peripheral neuropathy: Design of a ground-breaking phase III clinical study
18. Intradermal recombinant human nerve growth factor induces pressure allodynia and lowered heat-pain threshold in humans
19. Effects of insulin-like growth factors on organotypic cocultures of embryonic rat brainstem slices and skeletal muscle fibers
20. Low serum levels of nerve growth factor in diabetic neuropathy
21. IGF-I deficient mice show reduced peripheral nerve conduction velocities and decreased axonal diameters and respond to exogenous IGF-I treatment
22. Expression of insulin-like growth factor-I and related peptides during motoneuron regeneration
23. Elevated insulin-like growth factor (IGF) gene expression in sciatic nerves during IGF-supported nerve regeneration
24. Regulation of axonal caliber, neurofilament content, and nuclear localization in mature sensory neurons by nerve growth factor
25. Evidence indicating trophic importance of IGF-I in regenerating peripheral nerves
26. Neurotrophins promote motor neuron survival and are present in embryonic limb bud
27. Members of several gene families influence survival of rat motoneurons in vitro and in vivo
28. Effects of brain-derived neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease
29. Role of insulin-like growth factors in peripheral nerve regeneration
30. Evidence that brain-derived neurotrophic factor is a trophic factor for motor neurons in vivo
31. Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study
32. Nerve growth factor-induced hyperalgesia in the neonatal and adult rat
33. Insulin-like growth factor-I: Potential for treatment of motor neuronal disorders
34. The potential of insulin-like growth factor-I as a therapeutic for the treatment of neuromuscular disorders
35. Neurotrophic agents prevent motoneuron death following sciatic nerve section in the neonatal mouse
36. Brain-derived neurotrophic factor: An NGF-related neurotrophin
37. Nerve growth factor: Actions in the peripheral and central nervous systems
38. A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection: AIDS Clinical Trials Group Team 291
39. Enhanced synthesis of brain-derived neurotrophic factor in the lesioned peripheral nerve: Different mechanisms are responsible for the regulation of BDNF and NGF mRNA
40. Murine motor neuron disease (the wobbler mouse): Degeneration and regeneration of the lower motor neuron
41. Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF
42. Insulin-like growth factor I promotes nerve regeneration: An experimental study on rat sciatic nerve
43. Insulin-like growth factor II stimulates motor nerve regeneration
44. Insulin-like growth factors: Putative muscle-derived trophic agents that promote motoneuron survival
45. Biological studies of a putative avian muscle-derived neurotrophic factor that prevents naturally occurring motoneuron death in vivo
46. Brain-derived neurotrophic factor rescues developing avian motoneurons from cell death
47. The effect of systematically administered recombinant human nerve growth factor in healthy human subjects
48. An overview of the clinical experience with systemic administration of nerve growth factor in treating peripheral nervous system disorders
49. Neuroprotection by the inhibition of apoptosis
50. Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section
51. Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene
52. Effects of multiple subcutaneous doses of rhIGF-1 on total and free IGF-1 levels and blood glucose in humans
53. Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death
54. The biological responses of axotomized adult motoneurons to brain-derived neurotrophic factor
55. Nerve growth factor and the neurotrophic factor hypothesis
56. Therapeutic potential of neurotrophic factors for neurological disorders